Predictors of fatal outcomes among hospitalized COVID-19 patients with pre-existing hypertension in China.
Wang T, Tang R, Ruan H, Chen R, Zhang Z, Sang L, Su X, Yi S, Ni Z, Hu Y, Liu L, Shan H, Lei C, Peng Y, Liu C, Li J, Hong C, Zhang N, Zhong N, Li S; China Medical Treatment Expert Group for COVID-19.
Wang T, et al.
Clin Respir J. 2021 Aug;15(8):915-924. doi: 10.1111/crj.13382. Epub 2021 May 20.
Clin Respir J. 2021.
PMID: 33942518
Free PMC article.
Nearly one-third of the adult population is hypertensive worldwide, it is urgent to identify the factors that determine the clinical course and outcomes of COVID-19 patients with hypertension. ...CONCLUSION: Among COVID-19 patients with pre-existing hypertension, elevated …
Nearly one-third of the adult population is hypertensive worldwide, it is urgent to identify the factors that determine the clinical …